$162 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$61.90 - $92.18The lowest and highst price in the last 52 weeks.
0.0xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$1.43 (1.57%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$162 Billion|
|Dividend Yield||$1.43 (1.57%)|
|1 Year Return||+41.1%|
|Outstanding Shares||1.77 Billion|
|Avg 30 Day Volume||888 Thousand|
|Earnings per Share||$0.00|
|Price to Sales Ratio||-|
|Price to Book Ratio||-|
|Revenue to Enterprise Value||-|
|EBIT to Enterprise Value||-|
|Total Debt to Enterprise Value||-|
|Debt to Equity||-|
|Quarterly Earnings Growth (YoY)||-|
|Return on Equity||-|
|Return on Assets||-|
|Return on Invested Capital||-|
Let the games begin: Novo Nordisk takes the gold in Cowen''s ''R&D pentathlon'' Endpoints NewsEndpoints News, about 22 hours ago
The recent report titled Global Glucagon Drug Market and forecast to 2026 published by Reportsweb is a focused study encompassing the market segmentation primarily based on type and application. Th...OpenPR, 3 days ago
This report studies the Antidiabetic Biguanides Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information o...Jumbo News, 6 days ago